Ross Clark is a leader writer and columnist who has written for The Spectator for three decades. His books include Not Zero, The Road to Southend Pier, and Far From EUtopia: Why Europe is failing and Britain could do better
Just how strong an immunity do Covid patients develop after they have acquired the infection and how long does it last? The question is vital to the likely future passage of the pandemic, and to how well vaccines will protect us in the long term. Several studies have suggested there is a sharp decline in
Schools were the last institutions to close and can be expected to be the first to reopen. But just how big a part do schools play in the spread of Covid-19? The European Centre for Disease Prevention and Control has published a review of the evidence from 17 countries and concluded that the reopening of
Yesterday, the news was dominated by Imperial College’s React study which suggested – in contrast to the fall in recorded new infections – that the prevalence of Covid-19 in the general population was either static during the first ten days of lockdown (between 6 and 15 January), or could even have risen slightly. This morning,
Not for the first time, people could be excused for feeling a bit confused by conflicting data on Covid-19. This morning, many news outlets reported claims from the latest React study that levels of Covid-19 infections are no longer falling and may, in fact, be rising. This is somewhat at odds with government data that
For those trying to argue that the evils of colonialism still hang over former lands of the British Empire, the legacy of racism suppressing their ambitions and achievements, the Republic of Singapore presents something of a challenge. Just how did this particular colony manage to become not only one of the wealthiest countries in the
The UK’s decision to lengthen the gap between first and second doses of the Pfizer and AstraZeneca vaccines has been criticised by some. But what if we had a vaccine which only needed one dose, and had been tested on that basis? A vaccination programme could progress far more quickly and without the complication of
Of all the arguments put out against Brexit during the bitter referendum debate, one of the least convincing was that it would give a UK government the opportunity to repeal employment law, thereby impoverishing Britain and its people. Jeremy Corbyn once asserted that a Conservative government would turn the country into a ‘low-wage tax haven’. That
The World Health Organisation’s appeal to stop naming variants of Covid-19 after geographical locations evidently cut no ice with the Prime Minister, who warned MPs yesterday about a new Brazilian mutation of the Sars-Cov2-virus. Chief scientific adviser Sir Patrick Vallance later suggested to ITV News that the changes identified in the new variant ‘might make
A pattern seems to have emerged in the latter stages of the Covid crisis: Keir Starmer gets wind of discussions within government of possible new lockdown restrictions and calls for them to be implemented immediately – just to make it look as if he is ahead of the curve and the government behind it. We
With Covid-19 cases still rising a week into the third lockdown (and after several weeks of Tier 3 restrictions in London and the South East) the questions are inevitably being asked: why isn’t lockdown reducing transmission of the virus and do we need even more stringent rules, whatever they might be? While some studies claim
As with any crisis, Covid-19 has created great opportunities for some – and not just private companies selling PPE to the government at vastly-inflated prices. For some of the left, it has presented a chance to push for policies involving a much greater role for the state. With the government paying the wages of millions
What a strange non-event was the stockmarket reaction to the announcement of the latest national lockdown. Retailers, leisure companies, travel firms – all was calm. Marks and Spencer was down half a per cent on the morning, while Next was up five per cent on the back of good online results before Christmas. EasyJet was
Now that the Conservative party no longer has the issue of the EU over which to tear itself apart, is there something else that could replace it? Although perhaps not on the same scale as Europe, there is an issue which splits two of the party’s client groups: leasehold reform. On the one hand are
Was the latest release from the Office of National Statistics the shocking piece of evidence that led the Prime Minister to change his mind on children going back to school, and to introduce a full lockdown in England? The ONS does not usually publish its infection survey on Tuesdays – it usually comes out on
The government has failed to meet so many Covid-related targets so far that many will be extremely sceptical of the Prime Minister’s pledge on Monday evening to get the over-70s, front-line care workers and vulnerable people of all ages vaccinated by the middle of February. That is around 13 million first doses which will have to
Today begins the second phase of the Covid-19 vaccine programme, with the first members of the public receiving doses of the easier to use Oxford-AstraZeneca vaccine. But will the effort be thwarted by the emergence of two new variants of the SARS-CoV-2 virus, the Kentish strain and the South African strain? Yesterday, Sir John Bell,
Given that I know about as much about Lewis Hamilton’s tax affairs as I do about Formula One motor racing it would be unwise for me to be churlish about his knighthood, announced in the New Year Honours list. For all I know, he could be making generous voluntary donations to HMRC. A few weeks
How likely are you to be reinfected with the SARS-CoV-2 virus for a second time? It is a pertinent question because, at present, all government policy is predicated on the assumption that developing Covid-19 cannot be relied upon to offer you any immunity from reinfection whatsoever. Remember the Prime Minister telling us from his Number
What a joy it would be still to be in the EU. We could, for example, be part of the bloc’s Covid vaccine-buying programme. Or maybe not, to judge by the German experience. There has been a lot of comment in Britain regarding the relative slowness of the European Medicines Agency (EMA) in approving the Pfizer
It is easy to be offended by the idea of the super-rich trying to buy their place in the queue for the Covid-19 vaccine ahead of your granny, and easy to feel a warm glow of satisfaction that they are being rebuffed – all supplies are being held on such a tight rein by the
